The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(5-{3-[5-(2-Carboxy-ethyl)-thiophen-2-yl]-benzo[g]quinoxalin-2-yl}-thiophen-2-yl)-propionic acid ID: ALA366201
PubChem CID: 10206548
Max Phase: Preclinical
Molecular Formula: C26H20N2O4S2
Molecular Weight: 488.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCC(=O)O)s2)s1
Standard InChI: InChI=1S/C26H20N2O4S2/c29-23(30)11-7-17-5-9-21(33-17)25-26(22-10-6-18(34-22)8-12-24(31)32)28-20-14-16-4-2-1-3-15(16)13-19(20)27-25/h1-6,9-10,13-14H,7-8,11-12H2,(H,29,30)(H,31,32)
Standard InChI Key: YXYLSGIDXPMVNW-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
2.0167 -0.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0042 0.5833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3042 -0.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2917 0.9875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 1.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7375 -0.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4792 0.6750 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.8292 -1.4792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.5792 0.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5875 -0.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8000 1.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4875 -0.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -1.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0250 1.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1250 -0.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 0.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 -0.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6042 2.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0125 0.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1417 -3.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8458 0.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8458 -0.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3542 -0.3667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6542 -3.8917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8417 1.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9792 -2.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1917 0.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8000 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9625 -3.3042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4917 1.0583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5583 -0.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5583 0.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2708 0.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2708 -0.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 2 2 0
5 2 1 0
6 1 1 0
7 5 1 0
8 6 1 0
9 10 1 0
10 3 1 0
11 5 2 0
12 6 2 0
13 8 1 0
14 7 1 0
15 10 2 0
16 9 2 0
17 12 1 0
18 11 1 0
19 27 1 0
20 28 1 0
21 22 1 0
22 15 1 0
23 19 2 0
24 20 2 0
25 14 1 0
26 13 1 0
27 25 1 0
28 26 1 0
29 20 1 0
30 19 1 0
31 22 2 0
32 21 2 0
33 34 2 0
34 31 1 0
13 17 2 0
4 9 1 0
14 18 2 0
21 16 1 0
32 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 488.59Molecular Weight (Monoisotopic): 488.0864AlogP: 6.27#Rotatable Bonds: 8Polar Surface Area: 100.38Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.55CX Basic pKa: ┄CX LogP: 6.34CX LogD: 1.32Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.25Np Likeness Score: -0.45
References 1. Székelyhidi Z, Pató J, Wáczek F, Bánhegyi P, Hegymegi-Barakonyi B, Erös D, Mészáros G, Hollósy F, Hafenbradl D, Obert S, Klebl B, Kéri G, Orfi L.. (2005) Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives., 15 (13): [PMID:15925511 ] [10.1016/j.bmcl.2005.04.064 ]